Trial Profile
Phase I Clinical Study of RG7304 in Patients with Advanced Solid Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Jun 2016
Price :
$35
*
At a glance
- Drugs Avutometinib (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Chugai Pharmaceutical
- 05 Apr 2016 New trial record